Study of Rule-Based Algorithms in Anemia Management in Prevalent Hemodialysis Patients and Its Relation to Patients' Outcomes

Phase 1Active Not RecruitingNCT06996717

Ain Shams University145 enrolled

Overview

The study will assess role of rule based algorithm in anemia management in hemodialysis patients and its relation to patient's mortality

Study Type

INTERVENTIONAL

Allocation

Purpose

TREATMENT

Masking

NONE

Enrollment

145

Conditions

Anemia in End Stage Renal Disease

Interventions

ESADRUG

anemia management algorithm will successfully increase the number of patients in the target hemoglobin range

Eligibility

Sex: ALLMin age: 18 Years

Medical Language ↔ Plain English

Inclusion Criteria: * patients on hemodialysis for more than six months patients undergoing hemodialysis three times per week each session for 4 hours patients with urea reduction ratio\>65% patients with transferrin saturation\>20% Exclusion Criteria: * patients with terminal illness or malignancy patients receiving hemodialysis from catheter or arteriovenous graft

Locations (1)

Hemodialysis Units in Ain Shams University Hospitals

Cairo, Egypt

Outcomes

Primary Outcomes

Increase the number of patients in the target Hb range

This study will achieve better dosing of erythropoietin stimulating agents using rule based algorithms to correct anemia and avoid unnecessary extra doses of erythropoietin stimulating agents with their side effects

Time frame: 6 months

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.